BioIVT Appoints Global Business Strategist Lori Ball as Its Chief Operating Officer

Ms. Ball has held senior global leadership roles in the life sciences industry for more than 18 years

Westbury, NY –BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has appointed Lori Ball as its chief operating officer (COO). In her new position, Ms. Ball will be responsible for providing leadership and strategic direction on operational and business decisions, including growth planning, business and organizational development, risk management, and quality control.

“Lori has the requisite business expansion, global supply chain and regulatory expertise to help us take BioIVT through the next phase of its strategic growth plan. On a more granular level, Lori also has extensive sample management, clinical assessment and logistics experience. Lori shares our vision for making BioIVT the partner of choice for drug and diagnostic developers requiring clinically-detailed biospecimens or specialized research models and services. I am delighted to welcome Lori to the BioIVT executive team,” said BioIVT Chief Executive Officer (CEO) Jeffrey Gatz.

“I am excited to be joining BioIVT at this stage in its growth trajectory. Jeff has assembled a talented global team with the right experience, attention to detail, and commitment to high quality products and customer service. Together, we have the potential to dramatically enhance life science research,” said Ms. Ball.

Before joining BioIVT, Ms. Ball was president and CEO of LAB Strategies, LLC, a business strategy consultancy in the life sciences industry. Her areas of expertise include mergers and acquisitions, strategic planning, executive development, and segment analyses.

Prior to that, Ms. Ball served as president and COO of BioStorage Technologies, Inc. where she was responsible for multiple locations in Europe, Asia and North America. She was instrumental in helping the company become the premier, global provider of comprehensive sample management solutions for the life sciences industry, which resulted in selling the company to Brooks Automation.

Ms. Ball began building her international business acumen at Covance Inc., a drug development clinical research and central laboratory services organization, where she was global head of sales and commercial operations, supply chain, strategic sourcing and cold chain logistics for seven years.  

Ms. Ball has in-depth knowledge and experience of the global regulatory environment and was co-founder of The Global Initiative for the Ethical use of Human Specimens (the “GIFT Initiative”).

A strong mentor and a passionate advocate for her mentees, Ms. Ball has served as the National Board Chair for Pass the Torch for Women Foundation and is a member of the CICF Women’s Fund Board of Advisors. She also serves on the Anderson University Falls School of Business Marketing Advisory Board and Athletics Alumni Engagement Council.

Ms. Ball has a Master of Business Administration degree from Indiana Wesleyan University and a Bachelor of Arts degree from Anderson University.

About BioIVT

BioIVT, formerly BioreclamationIVT, is a leading global provider of research models and value-added research services for drug discovery and development. We specialize in control and disease-state biospecimens including human and animal tissues, cell products, blood, and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. Our PHASEZERO® Research Services team works collaboratively with clients to provide target and biomarker validation, phenotypic assays to characterize novel therapeutics, clinical assay development and in vitro hepatic modeling solutions. And as the premier supplier of ADME-toxicology model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly-discovered compounds and their effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in elevating science. For more information, please visit or follow the company on Twitter @BioIVT.

BioIVT Contact: Courtney Noah, Vice President of Marketing, 516-483-1196
Media Contact: Lisa Osborne, Rana Healthcare Solutions, 206-992-5245,